Triggers for research ethics consultation

Science Translational Medicine

Volumn 4, Issue 118, 2012, Pages

  Havard, Molly ^a   Cho, Mildred K ^a   Magnus, David ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; CLINICAL PROTOCOL; COMMUNITY TRIAL; DEVELOPING COUNTRY; DNA DETERMINATION; ETHNIC GROUP; EXPERIMENTAL THERAPY; HEALTH SERVICE; HUMAN; HUMAN RIGHTS; INCIDENTAL FINDING; INSTITUTIONAL REVIEW; MEDICAL RESEARCH; NOTE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROFESSIONAL STANDARD; PROGRAM DEVELOPMENT; PUBLIC-PRIVATE PARTNERSHIP; RESEARCH ETHICS; STEM CELL RESEARCH; STEM CELL TRANSPLANTATION; ARTICLE; CLINICAL TRIAL (TOPIC); CYTOLOGY; ECONOMICS; ETHICS; STEM CELL;

BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; DEVELOPING COUNTRIES; ETHICS CONSULTATION; ETHICS, RESEARCH; ETHNIC GROUPS; HUMANS; STEM CELLS;

EID: 84856305321     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3002734     Document Type: Note

References (33)

1. M. K. Cho, S. L. Tobin, H. T. Greely, J. McCormick, A. Boyce, D. Magnus, Strangers at the benchside: Research ethics consultation. Am. J. Bioeth. 8, 4-13 (2008).
2. I. de Melo-Martín, L. I. Palmer, J. J. Fins, Viewpoint: Developing a research ethics consultation service to foster responsive and responsible clinical research. Acad. Med. 82, 900-904 (2007).
3. N. Fost, paper presented at the American Society of Bioethics and Humanities Annual Meeting, Cleveland OH, 23 to 26 October 2008.
4. M. K. Cho, S. L. Tobin, H. T. Greely, J. McCormick, A. Boyce, D. Magnus, Research ethics consultation: The Stanford experience. IRB: Ethics & Human Research 30, 1-6 (2008).
5. L. M. Beskow, C. Grady, A. S. Iltis, J. Z. Sadler, B. S. Wilfond, Points to consider: The research ethics consultation service and the IRB. IRB: Ethics & Human Research 31, 1-9 (2009).
6. J. M. Ladd, M. D. Lappé, J. B. McCormick, A. M. Boyce, M. K. Cho, The "how" and "whys" of research: Life scientists'views of accountability. J. Med. Ethics 35, 762-767 (2009).
7. J. B. McCormick, A. M. Boyce, M. K. Cho, Biomedical scientists'perceptions of ethical and social implications: Is there a role for research ethics consultation? PLoS ONE 4, e4659 (2009).
8. B. Jacobs, J. Roffenbender, J. Collmann, K. Cherry, L. L. Bitsói, K. Bassett, C. H. Evans Jr., Bridging the divide between genomic science and indigenous peoples. J. Law Med. Ethics 38, 684-696 (2010).
9. A. Fleischman, C. Levine, L. Eckenwiler, C. Grady, D. E. Hammerschmidt, J. Sugarman, Dealing with the long-term social implications of research. Am. J. Bioeth. 11, 5-9 (2011).
10. L. F. Ross, A. Loup, R. M. Nelson, J. R. Botkin, R. Kost, G. R. Smith Jr., S. Gehlert, Human subjects protections in community-engaged research: A research ethics framework. J. Empir. Res. Hum. Res. Ethics 5, 5-17 (2010).
11. L. F. Ross, A. Loup, R. M. Nelson, J. R. Botkin, R. Kost, G. R. Smith Jr., S. Gehlert, The challenges of collaboration for academic and community partners in a research partnership: Points to consider. J. Empir. Res. Hum. Res. Ethics 5, 19-31 (2010).
12. L. Abbott, C. Grady, A systematic review of the empirical literature evaluating IRBs: What we know and what we still need to learn. J. Empir. Res. Hum. Res. Ethics 6, 3-19 (2011).
13. Code of Federal Regulations, Department of Health and Human Services, Protection of Human Subjects: 45 CFR 46 (2009), http://www.hhs.gov/ohrp/ humansubjects/guidance/45cfr46.html.
14. R. Zlotnik-Shaul, M. F. McKneally, Ethical considerations for innovations and clinical trials. Semin. Thorac. Cardiovasc. Surg. 15, 380-385 (2003).
15. L. Cendales, D. Granger, M. Henry, J. Jones, A. Langnas, D. Levi, J. Magee, R. Merion, K. Olthoff, T. Pruett, J. Roberts, M. Abecassis; ASTS VCA Ad Hoc Committee and Executive Committee, Implementation of vascularized composite allografts in the United States: Recommendations from the ASTS VCA Ad Hoc Committee and the Executive Committee. Am. J. Transplant. 11, 13-17 (2011).
16. OHRP, in Institutional Review Board Guidebook (1993), http://www.hhs.gov/ohrp/archive/irb/irb-guidebook.htm.
17. A. A. Lemke, S. B. Trinidad, K. L. Edwards, H. Starks, G. L. Wiesner; GRRIP Consortium, Attitudes toward genetic research review: Results from a national survey of professionals involved in human subjects protection. J. Empir. Res. Hum. Res. Ethics 5, 83-91 (2010).
18. S. M. Wolf, F. P. Lawrenz, C. A. Nelson, J. P. Kahn, M. K. Cho, E. W. Clayton, J. G. Fletcher, M. K. Georgieff, D. Hammerschmidt, K. Hudson, J. Illes, V. Kapur, M. A. Keane, B. A. Koenig, B. S. Leroy, E. G. McFarland, J. Paradise, L. S. Parker, S. F. Terry, B. Van Ness, B. S. Wilfond, Managing incidental findings in human subjects research: Analysis and recommendations. J. Law Med. Ethics 36, 219-248, 211 (2008).
19. D. Magnus, Translating stem cell research: Challenges at the research frontier. J. Law Med. Ethics 38, 267-276 (2010).
20. California Department of Public Health, Guidelines for Human Stem Cell Research (2009), http://www.cdph.ca.gov/programs/HSCR/Pages/ HSCRPublicHealthGuideline.aspx.
21. G. E. Henderson, L. R. Churchill, A. M. Davis, M. M. Easter, C. Grady, S. Joffe, N. Kass, N. M. King, C. W. Lidz, F. G. Miller, D. K. Nelson, J. Peppercorn, B. B. Rothschild, P. Sankar, B. S. Wilfond, C. R. Zimmer, Clinical trials and medical care: Defining the therapeutic misconception. PLoS Med. 4, e324 (2007).
22. L. M. Kopelman, Children as research subjects: Moral disputes, regulatory guidance, and recent court decisions. Mt. Sinai J. Med. 73, 596-604 (2006).
23. C. B. Fisher, S. Z. Kornetsky, E. D. Prentice, Determining risk in pediatric research with no prospect of direct benefit: Time for a national consensus on the interpretation of federal regulations. Am. J. Bioeth. 7, 5-10 (2007).
24. K. F. Holloway, Accidental communities: Race, emergency medicine, and the problem of polyheme. Am. J. Bioeth. 6, 7-17 (2006).
25. L. F. Ross, A. Loup, R. M. Nelson, J. R. Botkin, R. Kost, G. R. Smith Jr., S. Gehlert, Nine key functions for a human subjects protection program for community-engaged research: Points to consider. J. Empir. Res. Hum. Res. Ethics 5, 33-47 (2010).
26. H. T. Greely, Informed consent and other ethical issues in human population genetics. Annu. Rev. Genet. 35, 785-800 (2001).
27. P. Sankar, M. K. Cho, Genetics. Toward a new vocabulary of human genetic variation. Science 298, 1337-1338 (2002).
28. E. J. Emanuel, D. Wendler, J. Killen, C. Grady, What makes clinical research in developing countries ethical? The benchmarks of ethical research. J. Infect. Dis. 189, 930-937 (2004).
29. "International ethical guidelines for biomedical research involving human subjects" (Council for International Organizations of Medical Sciences and the World Health Organization, Geneva, 2002).
30. National Science Advisory Board for Biosecurity (Health and Human Services, Washington, DC, 2010).
31. M. Havard, D. Magnus, Beyond the IRB: Local service versus global oversight. Am. J. Bioeth. 11, 1-2 (2011).
32. H. K. Beecher, Ethics and clinical research. N. Engl. J. Med. 274, 1354-1360 (1966).
33. From the song "Frontiers," recorded by the rock band Journey; lyrics by Lee "Scratch" Perry.